Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.4.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
FY.4.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.103ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.103ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.103ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.103NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HC.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
HC.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HC.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HC.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FE.1.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FE.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FE.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FE.1.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.94ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.94ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.94ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.1.5.94NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GK.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.15.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.15.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.15.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GJ.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.21ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
FL.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FW.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FW.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FW.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JS.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JS.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JS.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JS.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.2.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.2.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.2.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used